Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Aclarion, Inc.: Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers | 2 | GlobeNewswire (USA) | ||
ACLARION Aktie jetzt für 0€ handeln | |||||
25.09. | Aclarion, Inc.: First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial | 2 | GlobeNewswire (USA) | ||
19.09. | Aclarion stock price target raised to $22 from $20 by Ascendiant Capital | 2 | Investing.com | ||
03.09. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
03.09. | Aclarion taps Greg Gould as CFO | 1 | Seeking Alpha | ||
03.09. | Aclarion names Greg Gould as new CFO to drive growth strategy | 1 | Investing.com | ||
03.09. | Aclarion, Inc.: Aclarion Appoints Greg Gould as Chief Financial Officer | 81 | GlobeNewswire (Europe) | HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations... ► Artikel lesen | |
14.08. | Aclarion, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
05.08. | Aclarion, Inc.: Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts | 125 | GlobeNewswire (Europe) | Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume... ► Artikel lesen | |
21.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
07.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
07.07. | Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
25.06. | Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery | - | RTTNews | ||
25.06. | Aclarion, Inc.: First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial | 3 | GlobeNewswire (USA) | ||
24.06. | Aclarion, Inc.: Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum | 1 | GlobeNewswire (USA) | ||
20.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
10.06. | Aclarion, Inc.: Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
30.05. | Aclarion stock price target cut to $20 at Ascendiant Capital | 2 | Investing.com | ||
30.05. | Kursziel für Aclarion-Aktie von Ascendiant Capital auf 20 US-Dollar gesenkt | 1 | Investing.com Deutsch | ||
26.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 26.05.2025 | 631 | Xetra Newsboard | The following instruments on XETRA do have their first trading 26.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.05.2025
Aktien
1 MXCFFM010000 Banco Invex S.A.
2... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 296,50 | +0,78 % | HeraMED beschleunigt seinen KI-Fahrplan - Die nächste Phase der Frauengesundheit beginnt jetzt | ||
INTUITIVE SURGICAL | 375,25 | -1,52 % | Opening Bell: Puma, Novo Nordisk, Droneshield, Rio Tinto, Robinhood, Intuitive Surgical | Alle Jahre wieder droht in den USA der Regierungsshutdown. Auch dieses Jahr. Demokraten und Republikaner haben sich noch nicht auf einen Haushalt geeinigt. Auswirkungen an der Börse waren noch nicht... ► Artikel lesen | |
THERMO FISHER | 452,75 | +9,60 % | Thermo Fisher Scientific Inc.: Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt | Der Geschäftsbereich PPD Clinical Research von Thermo Fisher Scientific, dem weltweit führenden Anbieter von wissenschaftlichen Dienstleistungen, hat heute eine neue Forschungs- und Entwicklungspartnerschaft... ► Artikel lesen | |
ROKU | 89,49 | +4,94 % | Which Roku streaming stick should you buy in 2025? My verdict after testing every model | ||
SERNOVA BIOTHERAPEUTICS | 0,107 | -2,73 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,728 | -1,62 % | Atossa Therapeutics appoints Janet Rea as SVP of R&D | ||
PING AN HEALTHCARE | 1,976 | +1,02 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting | -- Special Meeting to be held on September 26, 2025 --
SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders today, Evofem Biosciences, Inc.... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,011 | -12,31 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CENTENE | 30,500 | +0,33 % | Centene-Aktie: Kurs nur geringfügig im Minus (29,6357 €) | Am US-amerikanischen Aktienmarkt ist das Wertpapier von Centene aktuell unauffällig. Die Aktie notiert gegenwärtig bei 34,76 US-Dollar. Kaum auffällig ist derzeit an der Börse der Kurs von Centene.... ► Artikel lesen | |
CO-DIAGNOSTICS | 0,302 | +3,42 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
VERU | 3,820 | 0,00 % | VERU INC. - 8-K, Current Report | ||
QUIDELORTHO | 26,000 | +3,17 % | QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test | ||
CYTOSORBENTS | 0,761 | +0,40 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,300 | +0,61 % | PRESSESPIEGEL/Unternehmen: COMMERZBANK/UNICREDIT, SIEMENS HEALTHINEERS, LÜRSSEN WERFT, HSBC, CITIGROUP | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
COMMERZBANK/UNICREDIT - Der New Yorker Investor Metronuclear sieht die... ► Artikel lesen |